Abstract
BackgroundTGFβ signaling is associated with non-response to immune checkpoint blockade in patients with advanced metastatic cancers, particularly in patients with the immune excluded phenotype. While previous work demonstrates that converting...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
